Isofol Medical AB (publ) (FRA:5IU)

Germany flag Germany · Delayed Price · Currency is EUR
0.0536
+0.0032 (6.35%)
At close: Nov 28, 2025
-77.14%
Market Cap19.10M
Revenue (ttm)n/a
Net Income (ttm)-4.93M
Shares Outn/a
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0536
Previous Close0.0504
Day's Range0.0536 - 0.0536
52-Week Range0.0465 - 0.2375
Betan/a
RSI58.05
Earnings DateFeb 18, 2026

About Isofol Medical AB

Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2008
Employees 5
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 5IU
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.